{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:52:13Z","timestamp":1792713133075,"version":"4.5.0"},"reference-count":44,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,4,4]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>BOECs from VWD patients provide novel insight into the cellular mechanisms of the disease.<\/jats:p>","DOI":"10.1182\/blood-2012-06-435727","type":"journal-article","created":{"date-parts":[[2013,1,26]],"date-time":"2013-01-26T02:11:56Z","timestamp":1359166316000},"page":"2773-2784","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":86,"title":["Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells"],"prefix":"10.1182","volume":"121","author":[{"given":"Richard D.","family":"Starke","sequence":"first","affiliation":[{"name":"Vascular Sciences, National Heart and Lung Institute, Faculty of Medicine, Hammersmith Campus, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koralia E.","family":"Paschalaki","sequence":"additional","affiliation":[{"name":"Vascular Sciences, National Heart and Lung Institute, Faculty of Medicine, Hammersmith Campus, and"},{"name":"Airway Disease Department, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare E. F.","family":"Dyer","sequence":"additional","affiliation":[{"name":"MRC Laboratory of Molecular Cell Biology, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly J.","family":"Harrison-Lavoie","sequence":"additional","affiliation":[{"name":"MRC Laboratory of Molecular Cell Biology, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.","family":"Cutler","sequence":"additional","affiliation":[{"name":"Molecular Haemostasis Laboratory, Department of Haemostasis and Thrombosis, GSTS Pathology, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A. J.","family":"McKinnon","sequence":"additional","affiliation":[{"name":"Department of Haematology, National Heart and Lung Institute, Faculty of Medicine, Hammersmith Campus, Imperial College London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn M.","family":"Millar","sequence":"additional","affiliation":[{"name":"Department of Haematology, National Heart and Lung Institute, Faculty of Medicine, Hammersmith Campus, Imperial College London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Cutler","sequence":"additional","affiliation":[{"name":"MRC Laboratory of Molecular Cell Biology, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike A.","family":"Laffan","sequence":"additional","affiliation":[{"name":"Department of Haematology, National Heart and Lung Institute, Faculty of Medicine, Hammersmith Campus, Imperial College London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Randi","sequence":"additional","affiliation":[{"name":"Vascular Sciences, National Heart and Lung Institute, Faculty of Medicine, Hammersmith Campus, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2019111808583359600_B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-199701000-00001","article-title":"von Willebrand disease.","volume":"76","author":"Nichols","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"2019111808583359600_B2","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1002\/ajh.23142","article-title":"von Willebrand disease: clinical and laboratory lessons learned from the large von Willebrand disease studies.","volume":"87","author":"James","year":"2012","journal-title":"Am J Hematol"},{"issue":"4","key":"2019111808583359600_B3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1182\/blood-2007-12-130740","article-title":"Basal secretion of von Willebrand factor from human endothelial cells.","volume":"112","author":"Giblin","year":"2008","journal-title":"Blood"},{"issue":"pt 1","key":"2019111808583359600_B4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1242\/jcs.03494","article-title":"Formation and function of Weibel-Palade bodies.","volume":"121","author":"Metcalf","year":"2008","journal-title":"J Cell Sci"},{"issue":"3","key":"2019111808583359600_B5","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2010-01-264507","article-title":"Endothelial von Willebrand factor regulates angiogenesis.","volume":"117","author":"Starke","year":"2011","journal-title":"Blood"},{"issue":"9","key":"2019111808583359600_B6","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1182\/blood-2004-04-1396","article-title":"Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood.","volume":"104","author":"Ingram","year":"2004","journal-title":"Blood"},{"issue":"7","key":"2019111808583359600_B7","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1182\/blood-2007-08-105346","article-title":"Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin.","volume":"111","author":"Birdsey","year":"2008","journal-title":"Blood"},{"issue":"2","key":"2019111808583359600_B8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/hq0202.103997","article-title":"Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels.","volume":"22","author":"O\u2019Donnell","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"2019111808583359600_B9","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bbrc.2004.01.106","article-title":"Sorting of Von Willebrand factor to lysosome-related granules of haematopoietic cells.","volume":"315","author":"Ros\u00e9n","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2019111808583359600_B10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.devcel.2005.12.012","article-title":"The physiological function of von Willebrand\u2019s factor depends on its tubular storage in endothelial Weibel-Palade bodies.","volume":"10","author":"Michaux","year":"2006","journal-title":"Dev Cell"},{"issue":"6","key":"2019111808583359600_B11","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0049-3848(92)90050-K","article-title":"Multimeric analysis of von Willebrand factor by vertical sodium dodecyl sulphate agarose gel electrophoresis, vacuum blotting technology and sensitive visualization by alkaline phosphatase anti-alkaline phosphatase complex.","volume":"66","author":"Baillod","year":"1992","journal-title":"Thromb Res"},{"issue":"27","key":"2019111808583359600_B12","doi-asserted-by":"crossref","first-page":"24180","DOI":"10.1074\/jbc.M110.215194","article-title":"Intracellular storage and regulated secretion of von Willebrand factor in quantitative von Willebrand disease.","volume":"286","author":"Wang","year":"2011","journal-title":"J Biol Chem"},{"issue":"7","key":"2019111808583359600_B13","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/S0021-9258(18)42852-9","article-title":"Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations.","volume":"267","author":"Lyons","year":"1992","journal-title":"J Biol Chem"},{"issue":"10","key":"2019111808583359600_B14","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1182\/blood.V99.10.3637","article-title":"Tissue-type plasminogen activator (t-PA) is stored in Weibel-Palade bodies in human endothelial cells both in vitro and in vivo.","volume":"99","author":"Huber","year":"2002","journal-title":"Blood"},{"issue":"12","key":"2019111808583359600_B15","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1681\/ASN.2007111200","article-title":"Ischemia-induced exocytosis of Weibel-Palade bodies mobilizes stem cells.","volume":"19","author":"Kuo","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"2019111808583359600_B16","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1182\/blood-2008-05-158584","article-title":"Integrin alpha(v)beta(3) on human endothelial cells binds von Willebrand factor strings under fluid shear stress.","volume":"113","author":"Huang","year":"2009","journal-title":"Blood"},{"key":"2019111808583359600_B17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.cb.06.110190.001245","article-title":"Cell biology of von Willebrand factor.","volume":"6","author":"Wagner","year":"1990","journal-title":"Annu Rev Cell Biol"},{"key":"2019111808583359600_B18","author":"Cutler"},{"key":"2019111808583359600_B19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1538-7836.2009.03375.x","article-title":"von Willebrand factor assembly and secretion.","volume":"7","author":"Sadler","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2019111808583359600_B20","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1182\/blood-2003-02-0599","article-title":"Analysis of intracellular storage and regulated secretion of 3 von Willebrand disease-causing variants of von Willebrand factor.","volume":"102","author":"Michaux","year":"2003","journal-title":"Blood"},{"issue":"5","key":"2019111808583359600_B21","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1182\/blood-2008-08-173278","article-title":"A novel deletion mutation is recurrent in von Willebrand disease types 1 and 3.","volume":"114","author":"Sutherland","year":"2009","journal-title":"Blood"},{"issue":"6","key":"2019111808583359600_B22","first-page":"1127","article-title":"Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand disease\u2014single center comparison of four different assays.","volume":"84","author":"Federici","year":"2000","journal-title":"Thromb Haemost"},{"issue":"6","key":"2019111808583359600_B23","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood-2005-04-1758","article-title":"Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis.","volume":"107","author":"Hassenpflug","year":"2006","journal-title":"Blood"},{"issue":"5","key":"2019111808583359600_B24","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/j.1538-7836.2012.04675.x","article-title":"Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A\/M1606A and R1597W.","volume":"10","author":"Pruss","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2019111808583359600_B25","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/j.1538-7836.2012.04760.x","article-title":"Characterisation of von Willebrand factor A1 domain mutants I1416N and I1416T: correlation of clinical phenotype with flow-based platelet adhesion.","volume":"10","author":"McKinnon","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2019111808583359600_B26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1172\/JCI112560","article-title":"Transplantation of normal bone marrow into a pig with severe von Willebrand\u2019s disease.","volume":"78","author":"Bowie","year":"1986","journal-title":"J Clin Invest"},{"issue":"1","key":"2019111808583359600_B27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1172\/JCI8071","article-title":"Origins of circulating endothelial cells and endothelial outgrowth from blood.","volume":"105","author":"Lin","year":"2000","journal-title":"J Clin Invest"},{"issue":"1","key":"2019111808583359600_B28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/MOT.0b013e32833454b5","article-title":"Endothelial colony-forming cell role in neoangiogenesis and tissue repair.","volume":"15","author":"Critser","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"issue":"20","key":"2019111808583359600_B29","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1136\/heartjnl-2011-300920b.59","article-title":"Endothelial colony forming cells (ECFC) are senescent and dysfunctional in COPD due to reduced sirtuin-1 levels.","volume":"97","author":"Paschalaki","year":"2011","journal-title":"Heart"},{"issue":"10","key":"2019111808583359600_B30","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1538-7836.2009.03551.x","article-title":"An assessment of the pathogenic significance of the R924Q von Willebrand factor substitution.","volume":"7","author":"Berber","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2019111808583359600_B31","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood.V75.7.1466.1466","article-title":"Molecular studies of von Willebrand disease: reduced von Willebrand factor biosynthesis, storage, and release in endothelial cells derived from patients with type I von Willebrand disease.","volume":"75","author":"Ewenstein","year":"1990","journal-title":"Blood"},{"issue":"1","key":"2019111808583359600_B32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2141.1993.tb04636.x","article-title":"Type I von Willebrand disease, subtype \u2018platelet low\u2019: decreased platelet adhesion can be explained by low synthesis of von Willebrand factor in endothelial cells.","volume":"83","author":"Federici","year":"1993","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111808583359600_B33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3324\/haematol.2009.012336","article-title":"Premature termination codon mutations in the von Willebrand factor gene are associated with allele-specific and position-dependent mRNA decay.","volume":"95","author":"Plat\u00e8","year":"2010","journal-title":"Haematologica"},{"issue":"12","key":"2019111808583359600_B34","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1111\/j.1538-7836.2010.04060.x","article-title":"Alterations of mRNA processing and stability as a pathogenic mechanism in von Willebrand factor quantitative deficiencies.","volume":"8","author":"Castaman","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2019111808583359600_B35","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1365-2516.2008.01827.x","article-title":"A phase II prospective open-label escalating dose trial of recombinant interleukin-11 in mild von Willebrand disease.","volume":"14","author":"Ragni","year":"2008","journal-title":"Haemophilia"},{"issue":"8","key":"2019111808583359600_B36","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1073\/pnas.89.8.3531","article-title":"Vicinal cysteines in the prosequence play a role in von Willebrand factor multimer assembly.","volume":"89","author":"Mayadas","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2019111808583359600_B37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2010.03.003","article-title":"The genetic basis of von Willebrand disease.","volume":"24","author":"Goodeve","year":"2010","journal-title":"Blood Rev"},{"issue":"2","key":"2019111808583359600_B38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1182\/blood-2002-12-3693","article-title":"Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease.","volume":"102","author":"O\u2019Brien","year":"2003","journal-title":"Blood"},{"issue":"16","key":"2019111808583359600_B39","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood-2010-08-303727","article-title":"Pathologic mechanisms of type 1 VWD mutations R1205H and Y1584C through in vitro and in vivo mouse models.","volume":"117","author":"Pruss","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2019111808583359600_B40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2006-05-021105","article-title":"The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study.","volume":"109","author":"James","year":"2007","journal-title":"Blood"},{"issue":"3","key":"2019111808583359600_B41","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1182\/blood-2003-05-1505","article-title":"An amino acid polymorphism in von Willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13.","volume":"103","author":"Bowen","year":"2004","journal-title":"Blood"},{"issue":"1","key":"2019111808583359600_B42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1096-8652(199809)59:1<57::AID-AJH11>3.0.CO;2-Z","article-title":"Search for mutations in a segment of the exon 28 of the human von Willebrand factor gene: new mutations, R1315C and R1341W, associated with type 2M and 2B variants.","volume":"59","author":"Casa\u00f1a","year":"1998","journal-title":"Am J Hematol"},{"issue":"1","key":"2019111808583359600_B43","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"issue":"4","key":"2019111808583359600_B44","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood.V97.4.952","article-title":"The arginine-552-cysteine (R1315C) mutation within the A1 loop of von Willebrand factor induces an abnormal folding with a loss of function resulting in type 2A-like phenotype of von Willebrand disease: study of 10 patients and mutated recombinant von Willebrand factor.","volume":"97","author":"Ribba","year":"2001","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/14\/2773\/1364894\/2773.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/14\/2773\/1364894\/2773.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T20:54:49Z","timestamp":1644180889000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/14\/2773\/31126\/Cellular-and-molecular-basis-of-von-Willebrand"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,4]]},"references-count":44,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2013,4,4]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-06-435727","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,4]]}}}